Group One Trading’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Group One Trading’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-47,700	Closed	-$159K	–	6088
2019 Q4	$159K	Buy	+47,700	New	+$152K	﹤0.01%	3331
2019 Q1	–	Sell	-1,800	Closed	-$6K	–	5676
2018 Q4	$6K	Sell	1,800 -13,200	-88%	-$57.4K	﹤0.01%	4453
2018 Q3	$86K	Buy	15,000 +9,700	+183%	+$55.5K	﹤0.01%	3631
2018 Q2	$27K	Buy	+5,300	New	+$27.3K	﹤0.01%	4260
2017 Q3	–	Sell	-10,000	Closed	-$46K	–	5380
2017 Q2	$46K	Buy	10,000 +1,900	+23%	+$8.48K	﹤0.01%	3550
2017 Q1	$40K	Buy	+8,100	New	+$78K	﹤0.01%	3545

Group One Trading's FOMX Position: Q1 2020 in Review

Group One Trading sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 26,791 shares — an estimated $89K sold.

Group One Trading first reported a position in FOMX in Q1 2017 and held it in 6 quarters. The position peaked at $164K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Group One Trading reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Group One Trading sold 26,791 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $89K.
Group One Trading first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2017 and held it in 6 quarters.
Group One Trading's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $164K in Q3 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.